Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cg Oncology Inc (CGON)

Cg Oncology Inc (CGON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,180,391
  • Shares Outstanding, K 67,630
  • Annual Sales, $ 200 K
  • Annual Income, $ -48,610 K
  • EBIT $ -96 M
  • EBITDA $ -99 M
  • 60-Month Beta N/A
  • Price/Sales 10,873.84
  • Price/Cash Flow N/A
  • Price/Book 4.10

Options Overview Details

View History
  • Implied Volatility 94.44% ( -0.48%)
  • Historical Volatility 46.09%
  • IV Percentile 56%
  • IV Rank 60.69%
  • IV High 154.72% on 05/02/24
  • IV Low 1.40% on 03/13/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 180
  • Volume Avg (30-Day) 53
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 639
  • Open Int (30-Day) 1,147

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.38
  • Number of Estimates 3
  • High Estimate -0.30
  • Low Estimate -0.47
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.28 +3.39%
on 11/21/24
40.47 -20.09%
on 11/11/24
-4.37 (-11.90%)
since 10/21/24
3-Month
31.28 +3.39%
on 11/21/24
40.47 -20.09%
on 11/11/24
-4.22 (-11.54%)
since 08/21/24

Most Recent Stories

More News
CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 25th Annual Meeting

CGON : 32.34 (+0.31%)
CG Oncology Reports Third Quarter 2024 Financial Results and Provides Business Updates

CGON : 32.34 (+0.31%)
CG Oncology Announces Nature Medicine Publication of Phase 1b Study Results Evaluating Cretostimogene Grenadenorepvec in Combination with Nivolumab in Muscle-Invasive Bladder Cancer

CGON : 32.34 (+0.31%)
Discover the 3 Best-Performing Biotech IPO Stocks of 2024

Check out which three biotechnology companies that went public in 2024 and are performing the best and a big factor influenced their rise.

UPB : 17.80 (-1.17%)
JNJ : 155.50 (+1.56%)
CGON : 32.34 (+0.31%)
AVBP : 26.59 (-2.99%)
Everyone's Talking About These 2 Biotech IPO Stocks, But Are They Buys?

The market's excited for these stocks, but there's no rush to buy them.

KYTX : 3.99 (-3.16%)
CGON : 32.34 (+0.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology is based in IRVINE, Calif.

See More

Key Turning Points

3rd Resistance Point 35.11
2nd Resistance Point 34.13
1st Resistance Point 33.24
Last Price 32.34
1st Support Level 31.36
2nd Support Level 30.38
3rd Support Level 29.49

See More

52-Week High 50.23
Fibonacci 61.8% 40.89
Fibonacci 50% 38.00
Fibonacci 38.2% 35.11
Last Price 32.34
52-Week Low 25.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar